Joseph Romeo, MD
Otolaryngology/Facial Plastic Surgery · Turlock, CANPI 1679521033
Payments from drug & device makers
What this record shows
Stryker accounts for 83.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,522 and has fallen 98.5% since, to $23 in 2025.
Across 46 payments — averaging $40.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Acclarent, Inc$162
- Smith+Nephew$72
- Sanofi Pasteur Inc.$24
- Medtronic$23
- Aerin Medical Inc.$20
- plus $13 from 1 others
What the payments were for
- Travel & lodging$86346%
- Food & beverage$1,01854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 33 | $1,567 |
| Acclarent, Inc | 6 | $162 |
| Smith+Nephew | 3 | $72 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Medtronic | 1 | $23 |
| Aerin Medical Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,881 in reported general payments places this provider in the 60th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 29 | $1,813 |
| Omeprazole | 73 | $715 |
| Ipratropium Bromide | 11 | $399 |
| Fluticasone Propionate | 28 | $278 |
| Azelastine Hcl | 13 | $250 |
| Ondansetron OdtOndansetron | 33 | $226 |
| Ciprofloxacin Hcl | 27 | $216 |
| Mupirocin | 28 | $212 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $185 |
| Cefdinir | 13 | $155 |
| Cephalexin | 18 | $135 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Turlock
- Maansi DoshiTurlock$3K
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
- Paul NassifBeverly Hills$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.